Skip to main content
. 2022 Apr-Jun;26(2):255–260. doi: 10.5935/1518-0557.20210065

Table 3.

Descriptive analysis of patients’ demographics, response to COS and laboratorial ICSI outcomes in repeated cycles.

Variables r-hCG Trigger 1st Cycle (n=18) r-hCG Trigger 2nd Cycle (n=18) p-value
Female age (years) 37.44±0.14 37.44±0.14 >0.999
Male age (years) 38.72±1.65 39.11±1.65 0.868
Female BMI 24.72±0.95 25.00±0.95 0.833
FSH dose (IU) 2620.59±154.62 2841.67±150.26 0.305
Length of stimulation (days) 10.41±1.70 10.94±1.75 0.377
Length of pituitary suppression (days) 4.88±1.17 4.88±1.17 >0.999
Number of follicles 10.00±2.44 12.50±2.44 0.468
Mature follicular rate (%) 44.97±26.90 35.57±18.26 0.242
Estradiol level (pg/mL) 1520.31±227.97 1556.69±322.40 0.927
Number of retrieved oocytes 6.00±1.87 9.56±1.87 0.178
Oocyte yield (%) 61.81±2.62 72.23±2.62 0.190
MII oocyte rate (%) 62.41±2.63 65.54±2.63 0.686
MI oocyte rate (%) 17.00±1.30 12.72±1.08 0.011
PI oocyte rate (%) 9.09±0.91 10.00±0.79 0.450
Fertilization rate (%) 66.25±2.88 67.92±2.38 0.655
Blastocyst development rate (%) 19.75±2.14 34.51±1.79 0.145

Note: Retrospective case-control within-subject analysis performed to compare the response to COS and ICSI outcomes in patients who had two consecutive ICSI cycles triggered with r-hCG only. Values are mean ± standard error, unless otherwise noted. COS – controlled ovarian stimulation, ICSI – intracytoplasmic sperm injection, r-hCG – recombinant human chorionic gonadotropin.